Pearls & Perspectives: Updates in testosterone therapy, with Andrew Sun, MD at AUA 2025
In this episode of Pearls and Perspectives, host Amy Pearlman, MD sits down with Andrew Y. Sun, MD, during the American Urological Association's (AUA) 2025 Annual Meeting in Las Vegas, NV to explore c...
27 Huhti 202514min
Pearls & Perspectives: Helen Bernie, DO, MPH, at AUA 2025
In this episode of Pearls and Perspectives from Urology Times, host Amy Pearlman, MD, sits down with Helen Bernie, DO, MPH, at the American Urological Association's (AUA) 2025 Annual Meeting in Las Ve...
27 Huhti 202518min
Introducing Pearls & Perspectives, with Amy Pearlman, MD!
Introducing Pearls & Perspectives! Pearls and Perspectives is a new podcast from Urology Times, hosted by board-certified urologist Amy Pearlman, MD. This series explores the latest in urologic care,...
21 Huhti 20253min
Treatment Strategies to Tackle NMIBC Heterogeneity
Panelists examine disease heterogeneity in NMIBC and discuss a balanced treatment approach that prioritizes patient quality of life and surgery effectiveness.
2 Huhti 202530min
Subgroup Analyses and Clinical Insights in Metastatic Hormone-Sensitive Prostate Cancer Treatment
Jack R. Andrews, MD; Eugene B. Cone MD; and Edwin Posadas, MD, FACP, discuss how early intervention with individualized treatment approaches based on disease volume, patient characteristics, and bioma...
2 Huhti 202546min
Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges
Wayne Kuang, MD; and Matt T. Rosenberg, MD, discuss how overactive bladder presents with distinct pathophysiological mechanisms between genders, requires different diagnostic approaches when distingui...
5 Maalis 202541min
Current and Emerging Treatment Landscape of mHSPC
Jack Andrews MD; Eugene Cone, MD; and Arash Rezazadeh, MD, discuss how metastatic hormone-sensitive prostate cancer presents clinically, explore current treatment standards including combination thera...
25 Helmi 202536min
Identifying Patients with Intermediate Risk in NMIBC
Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.
29 Tammi 202530min
